Antipsychotic medication and seizures: A review

被引:116
作者
Hedges, D [1 ]
Jeppson, K
Whitehead, P
机构
[1] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA
[2] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA
[3] Utah State Hosp, Provo, UT USA
关键词
D O I
10.1358/dot.2003.39.7.799445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Both first-generation and second-generation antipsychotic medications can lower the seizure threshold, increasing the chances of seizure induction. This article reviews the published literature concerning the seizure-lowering effects of first- and second-generation antipsychotic medication. Unfortunately, rigorously controlled studies are relatively infrequent, and case reports form a large part of the available literature, limiting the confidence with which firm conclusions can be drawn. Of the first-generation antipsychotic medications, chlorpromazine appears to be associated with the greatest risk of seizure provocation, although other first-generation anti-psychotics also lower seizure threshold. Conversely, molindone, haloperidol, fluphenazine, pimozide and trifluoperazine are associated with a lower risk of seizure induction. Clozapine is the second-generation antipsychotic most frequently associated with seizures, with risperidone appearing to confer a relatively low risk. Other factors such as history of seizure activity, concurrent use of other drugs that lower seizure threshold, rapid dose titration, slow drug metabolism, metabolic factors and drug-drug interactions appear to increase the chances of an antipsychotic medication inducing seizure activity. (C) 2003 Prous Science. All rights reserved.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 52 条
[1]   Effects of risperidone in overdose [J].
Acri, AA ;
Henretig, FM .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1998, 16 (05) :498-501
[2]  
Alldredge BK, 1999, NEUROLOGY, V53, pS68
[3]  
ALTONSTEPHENS D, 1953, J MEN SCI, V100, P543
[4]   PRELIMINARY OBSERVATIONS ON THE PSYCHIATRIC USES OF CHLORPROMAZINE (LARGACTIL) [J].
ANTONSTEPHENS, D .
JOURNAL OF MENTAL SCIENCE, 1954, 100 (419) :543-557
[5]   Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone [J].
Basson, BR ;
Kinon, BJ ;
Taylor, CC ;
Szymanski, KA ;
Gilmore, JA ;
Tollefson, GD .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (04) :231-238
[6]  
Bonanno DG, 2001, ANN PHARMACOTHER, V35, P563
[7]  
*BRIST MEYER SQUIB, 2003, DAT FIL
[8]  
Casey DE, 1996, J CLIN PSYCHIAT, V57, P40
[9]   EEG abnormalities during treatment with typical and atypical Antipsychotics [J].
Centorrino, F ;
Price, BH ;
Tuttle, M ;
Bahk, WM ;
Hennen, J ;
Albert, MJ ;
Baldessarini, RJ .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (01) :109-115
[10]   A case of pharmacokinetic interference in comedication of clozapine and valproic acid [J].
Conca, A ;
Beraus, W ;
König, P ;
Waschgler, R .
PHARMACOPSYCHIATRY, 2000, 33 (06) :234-235